(Q52661962)

English

Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.

scientific article published on 21 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

steatohepatitis

0 references

Ryuichi Noguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Tadashi Namisaki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Kei Moriya

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Mitsuteru Kitade

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yosuke Aihara

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Akitoshi Douhara

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Norihisa Nishimura

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Kosuke Takeda

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yasushi Okura

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hideto Kawaratani

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hiroaki Takaya

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Kenichiro Seki

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hitoshi Yoshiji

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

21 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

162-172

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Dual blockade of angiotensin-II and aldosterone suppresses the progression of a non-diabetic rat model of steatohepatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Regulation of tight junction permeability by intestinal bacteria and dietary components

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

Mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1104-X

21 January 2018

(Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid dose-dependently improves liver injury in rats fed a methionine- and choline-deficient diet

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid modifies gut-derived endotoxemia in neonatal rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical aspects of non-alcoholic fatty liver disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of bile acids on endotoxin in vitro and in vivo (physico-chemical defense). Bile deficiency and endotoxin translocation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidative effect of ursodeoxycholic acid in the liver of rats with oxidative stress caused by gamma-irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut microbiota and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26190501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-015-1104-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26190501%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52661962&oldid=1446996221"